medigraphic.com

2006, Number 2

<< Back Next >>

Rev Med Inst Mex Seguro Soc 2006; 44 (2)

Medical Schools: Opportunities to Improve Drug Prescription

Izazola-Conde C

Language: Spanish
References: 43
Page: 139-146
PDF size: 74.58 Kb.


ABSTRACT

This paper reviews different strategies to improve medical prescription. Medical schools, respon-sible for the education and updating of physicians, should strengthen educative strategies, both curricular and extracurricular. They must also support managerial and regulatory strategies in collaboration with institutions that provide health services and governmental health ministries. Some characteristics of rational and irrational medicinal prescription are listed. Some educa-tional strategies are described, such as a de-crease in the number of drugs reviewed during pharmacology courses, the inclusion of the concept of essential medicines, the use of sources of information about drugs, and problem-based learning. Some managerial strategies are mentioned, such as a research on medicine use and the production of therapeutic guidelines that require the involvement of health services pro-viders and that might be supported by medical schools. This paper also points out the need for continuing medical education and explains some related experiences that have been successful in improving drug prescription prac-tices in other countries.


REFERENCES

  1. 1. World Health Organization. The World Medicines Situation. WHO/EDM/PAR/2004.5.2004. Disponible en: http://www.who.int/medicines/organization/par/World_Medicines_Situation.pdf

  2. 2. World Health Organization. Global comparative expenditures with related reference information. Health economics and drugs. Essential Drugs and Medicines Policy Series No. 3 (EDM/PAR/2000.2). Geneva: World Health Organization; 2000.

  3. 3. Levy MY, Reidenberg MM. What has been the impact of the concept of essential drugs? Clin Pharmacol Ther 2003;73(4):275-278.

  4. 4. Quick JD. Ensuring access to essential medicines in the developing countries: A framework for action. Clin Pharmacol Ther 2003;73(4):279-283.

  5. 5. Editorial. Boletín de Medicamentos Esenciales 1988;7:1.

  6. 6. Herxheimer A. Cinco niveles del uso racional de los medicamentos. Boletín de Medicamentos Esenciales 1988;7:19.

  7. 7. Quick JO, Rankin JR, Laing RO, O’Connor RW, Hogerzeil HV, Dukes MNG, Garnett A, editors. Managing drug supply. The selection, procurement, distribution and use of pharmaceuticals. Second edition. Connecticut: Kumarian Press; 1997.

  8. 8. Anis AH, Carruthers G, Carter AO, Kierulf J. Variability in prescription drug utilization: issues for research. Can Med Assoc J 1996;154(5):635-640.

  9. 9. Riley MW. Reducing “information overload” in the teaching of Pharmacology: the “200 Drug List” J Med Educ 1984;59(6):508-511.

  10. Rodríguez R, Vidrio H, López-Martínez E, Contreras E, Valenzuela F. Changing the countenance of pharmacology courses in medical schools. Trend Pharm Sci 1997;18:314-318.

  11. Hogerzeil HV. The concept of essential medicines: lessons for rich countries. BMJ 2004;329:1169-1172.

  12. Bapna JS. Education on the concept of essential drugs and rationalized drug use. Clin Pharmacol Ther 1989;45(3):217-219.

  13. Mabadeje AFB, Akintowa AA, Ashorobi RB. The value and effects of implementing an essential drugs list in the Lagos University teaching hospital. Clin Pharmacol Ther 1991;50(2):121-124.

  14. Izazola-Conde C, Luján M. Práctica: “Prescripción de medicamentos”. En: Rodríguez R, Luján M. editores. Manual de prácticas de farmacología. México: Facultad de Medicina. Universidad Nacional Autónoma de México; 1996.

  15. Izazola-Conde C. Las recetas médicas como un medio para conocer algunas características de la prescripción de medicamentos. Memorias del XIV Congreso Nacional de Farmacología, México, Instituto Nacional de Cardiología Ignacio Chávez, 1991.

  16. Izazola-Conde C, García E, Girón AL, Álvarez S, Lemini C. El análisis de recetas médicas como una estrategia didáctica para promover la prescripción racional de los medicamentos. Memorias del XVII Congreso de la Asociación Mexicana de Farma-cología, Morelia, Mich., México; 1994.

  17. Rodríguez R, Téllez-Villagra, Martínez-González, Santana C. Retención de los conocimientos de cien-cias básicas por los alumnos de medicina. Impli-caciones educativas. Rev Fac Med 1992;35(1):23-28.

  18. de Vries TPGM, Henning RH, Hogerzeil HV, Fresle DA. Guía de la buena prescripción. OMS/DAP/94.11. OMS: Ginebra; 1998.

  19. De Vries TPGM, Henning RH, Hogerzeil HV, Bapna JS, Biro L, Kafle KK, Mabadeje AFB, Santoso B, Smith AJ. Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomized controlled study. Lancet 1995;346(2):1454-1457.

  20. Vestal RE, Benowitz NL. Workshop on problem-based learning as a method for teaching clinical pharmacology and therapeutics in medical school. J Clin Pharmacol 1992;32:779-797.

  21. Gassman N. Políticas farmacéuticas en México a través del tiempo. Alerta Farmacéutica 1996;9:1-27.

  22. Facultad de Medicina. Programa de estudios de seminario clínico. México: Facultad de Medicina, Universidad Nacional Autónoma de México; 2004. p. 53.

  23. Facultad de Medicina. Programa de Estudios Teórico-Práctico de Farmacología. México: Facul-tad de Medicina, Universidad Nacional Autónoma de México; 2004. p. 173.

  24. Ethical criteria for medicinal drug promotion. Who Drug Information 1994;8(3):157-160.

  25. Alván G. Drug information: a service provided by cli-nical pharmacologists. Trends Pharm Sci 1985; 6:1-4.

  26. Öhlman B, Alván G. Red de información para prescriptores suecos. Boletín de Medicamentos Esenciales 1991. p. 12.

  27. Herxheimer A. Los boletines de medicamentos farmacéuticos independientes satisfacen una ne-cesidad crítica. Boletín de Medicamentos Esen-ciales 1995;19:17.

  28. Soumerai SB, Avorn J. Principles of educational outreach (“academic detailing”) to improve clinical decision making. JAMA 1990;263(4):549-556.

  29. Soumerai SB, Avorn J. Economic and policy analysis of university-based drug “detailing”. Med Care 1986;24(4):313-331.

  30. Gutiérrez G, Guiscafré H, Bronfman M, Walsh J, Martínez H, Muñoz O. Changing physician prescribing patterns: evaluation of an educational strategy for acute diarrhea in Mexico City. Med Care 1994;32(5):436-446.

  31. Laporte JR, Tognoni G, editores. Principios de epidemiología del medicamento. Primera edición. Barcelona: Salvat; 1983.

  32. Quick JD, Laing RO, Ross-Degnan D. Inter-vention research to promote clinically effective and economically efficient use of pharmaceuticals: the international network for rational use of drugs. J Clin Epidemiol 1991;44(Suppl 11): 575-655.

  33. Hogerzeil HV, et al. Field tests for rational drug use in twelve developing countries. Lancet 1993; 342:1408-1410.

  34. Lipton HL, Bird JA. Drug utilization review in am-bulatory settings: state of the science and directions for outcomes research. Med Care 1993;31:1069-1082.

  35. Le Grand A, Hogerzeil HV, Haaijer-Ruskamp F. Intervention research in rational use of drugs: a review. Health Pol Plann 1999;14(2):89-102.

  36. Homedes N, Ugalde A. Improving the use of pharmaceuticals through patient and community level interventions. Soc Sci Med 2001;52:99-134.

  37. Guiscafré H, Martínez H, Reyes H, Pérez-Cuevas R, Castro R, Muñoz O, Gutiérrez G. From research to public health interventions. I. Impact of an educational strategy for physicians to improve treatment practices of common diseases. Arch Med Res 1995;26(Suppl ):S31-S39.

  38. Organización Mundial de la Salud. Cómo investigar el uso de los medicamentos en los servicios de salud. Indicadores seleccionados del uso de medicamentos. Programa de Acción sobre Medicamentos Esenciales. Ginebra: OMS/DAP/93.1, OMS; 1993.

  39. McGavock H. Facilitar a los médicos familiares la autorregulación de sus prescripciones. Boletín de Medicamentos Esenciales 1990;9:4-5.

  40. Sunartono y Darminto: De la investigación a la acción: la experiencia de Gunungkidul. Boletín de Medicamentos Esenciales 1995;20:21-22.

  41. Harvey K. Directrices terapéuticas. Boletín de Medicamentos Esenciales 1995;19:10-11.

  42. Petrie J. Directrices clínicas en Escocia: un signo de los tiempos. Boletín de Medicamentos Esenciales 1996;22:13-14.

  43. Reyes MH. Introducción a la guías clínicas. Rev Med IMSS 2003;41(Supl):S1-S2.




2020     |     www.medigraphic.com